Overall, 14 shares were trading in green in Nifty50 index, while 36 were trading in red in the afternoon trade.

Overall, 33 shares were trading in green in Nifty50 index, while 17 were trading in red in the afternoon trade.

Overall, 38 shares were trading in green in Nifty50 index, while 12 were trading in red in the afternoon trade.

Overall, 35 shares were trading in green in Nifty50 index, while 15 were trading in red in the afternoon trade.

Overall, 31 shares were trading in green in Nifty50 index, while 19 were trading in red.

The results of these companies are likely to be missed in today’s action-packed day.

Among the 50 components in the Nifty index, 18 shares were trading in the green, while 32 were in the red.

Among the 50 components in the Nifty index, 24 shares were trading in the green, while 26 were in the red.

"Play the churn as regional players turn national biggies in both B2C and B2B segments."

Market participants have turned bullish on leading pharma companies in recent times as they continued to gain share in existing products.

Amrutanjan Healthcare today reported a net profit of Rs 5.08 crore for October-December, 2013, against that of Rs 2.03 crore in the same pe...

Earlier, EHCL was licensee for Tiger balm, and with its own brands, Elder Healthcare has projected a turnover of Rs 300 crore by year 2013.

It has been overtaken by the likes of Zandu Balm. Attempts in the recent past to take the company beyond pain balm have failed.

Amrutanjan Health Care today said it has fixed Rs 900 per share as the price for its buy back offer for equity shares.

The company said "the buy back shall not exceed 10 per cent of the paid up share capital and the price will be determined at a late date".

More than a century old cold balm maker, Amrutanjan is respositioning itself to become a complete family-oriented healthcare brand.

Is the Chennai-based 100-year-old cold balm-maker Amrutanjan, a possible takeover target on Dabur India’s radar?